Cellectis (CLLS) Stock Chart & Stock Price History → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free CLLS Stock Alerts $2.51 +0.02 (+0.80%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Cellectis Stock Price Performance5 Day Performance-5.09%1 Month Performance-6.16%3 Month Performance-15.64%6 Month Performance+149.31%Year-To-Date Performance-18.65%1 Year Performance+29.15% Receive CLLS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cellectis and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> CLLS Stock Chart for Saturday, April, 27, 2024 CLLS Chart by TradingView Cellectis Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$2.49$2.51+0.63%$2.51$2.35223,279 shs$139.26 million04/25/2024$2.50$2.49-0.40%$2.61$2.4714,710 shs$138.39 million04/24/2024$2.62$2.50-4.57%$2.57$2.4839,291 shs$138.95 million04/23/2024$2.64$2.62-0.77%$2.65$2.4647,230 shs$145.60 million04/22/2024$2.55$2.64+3.53%$2.65$2.5923,573 shs$146.73 million04/19/2024$2.47$2.55+3.24%$2.58$2.5111,743 shs$141.73 million Get the Latest News and Ratings for CLLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cellectis and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$2.46$2.47+0.41%$2.63$2.3014,972 shs$137.28 million04/17/2024$2.49$2.46-1.20%$2.61$2.456,942 shs$136.73 million04/16/2024$2.62$2.49-4.96%$2.65$2.4984,223 shs$138.39 million04/15/2024$2.69$2.62-2.60%$2.65$2.5441,919 shs$145.62 million04/12/2024$2.80$2.69-3.93%$2.80$2.6760,016 shs$149.51 million04/11/2024$2.79$2.80+0.36%$2.86$2.7814,726 shs$155.64 million04/10/2024$2.75$2.79+1.45%$2.81$2.6610,825 shs$155.08 million04/09/2024$2.69$2.75+2.23%$2.82$2.7020,196 shs$152.85 million04/08/2024$2.68$2.69+0.37%$2.89$2.6081,817 shs$149.51 million04/05/2024$2.75$2.70-1.82%$2.74$2.6612,974 shs$150.07 million04/04/2024$2.79$2.75-1.43%$2.89$2.7221,287 shs$152.85 million04/03/2024$2.62$2.79+6.49%$2.95$2.6645,942 shs$155.07 million04/02/2024$2.57$2.62+1.95%$2.69$2.5636,851 shs$145.62 million04/01/2024$2.65$2.57-3.02%$2.64$2.4142,508 shs$142.84 million03/29/2024$2.65$2.65$2.75$2.6544,068 shs$147.29 million03/28/2024$2.67$2.65-0.75%$2.75$2.6544,022 shs$147.29 million03/27/2024$2.50$2.67+6.80%$2.71$2.507,361 shs$148.40 million03/26/2024$2.58$2.50-3.10%$2.60$2.4335,396 shs$138.95 million03/25/2024$2.50$2.58+3.20%$2.58$2.3828,149 shs$138.96 million03/22/2024$2.53$2.50-1.19%$2.53$2.4220,611 shs$138.95 million03/21/2024$2.45$2.53+3.27%$2.55$2.4115,456 shs$140.62 million03/20/2024$2.41$2.45+1.66%$2.45$2.3517,271 shs$136.17 million03/19/2024$2.49$2.41-3.21%$2.47$2.3825,511 shs$133.95 million03/18/2024$2.54$2.49-1.97%$2.56$2.4324,604 shs$138.39 million03/15/2024$2.53$2.54+0.40%$2.65$2.4333,504 shs$141.17 million03/14/2024$2.57$2.53-1.56%$2.67$2.4626,401 shs$140.62 million03/13/2024$2.62$2.57-1.91%$2.65$2.5524,864 shs$142.84 million03/12/2024$2.43$2.62+7.82%$2.68$2.4736,536 shs$145.62 million03/11/2024$2.59$2.43-6.18%$2.68$2.4312,379 shs$135.07 million03/08/2024$2.51$2.59+3.19%$2.78$2.5345,890 shs$143.95 million03/07/2024$2.54$2.51-0.99%$2.58$2.4539,127 shs$139.51 million03/06/2024$2.48$2.54+2.22%$2.55$2.5129,852 shs$140.90 million03/05/2024$2.59$2.48-4.25%$2.56$2.4192,366 shs$137.84 million03/04/2024$2.65$2.59-2.26%$2.65$2.5630,639 shs$143.95 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>03/01/2024$2.58$2.65+2.71%$2.65$2.5321,385 shs$147.29 million02/29/2024$2.60$2.58-0.77%$2.60$2.5226,363 shs$143.40 million02/28/2024$2.72$2.60-4.41%$2.63$2.53120,206 shs$144.51 million02/27/2024$2.72$2.72$2.78$2.6061,852 shs$151.18 million02/26/2024$2.83$2.72-3.89%$2.81$2.6578,666 shs$151.19 million02/23/2024$2.93$2.83-3.41%$2.91$2.7779,234 shs$157.29 million02/22/2024$2.86$2.93+2.45%$2.95$2.8034,358 shs$162.85 million02/21/2024$2.73$2.86+4.76%$2.86$2.7156,737 shs$158.96 million02/20/2024$2.89$2.73-5.54%$2.85$2.7287,426 shs$151.73 million02/19/2024$2.89$2.89$2.92$2.8222,600 shs$160.63 million02/16/2024$2.85$2.89+1.40%$2.92$2.8222,698 shs$160.64 million02/15/2024$2.85$2.85$2.94$2.8312,173 shs$158.40 million02/14/2024$2.79$2.85+2.15%$2.85$2.7724,694 shs$158.40 million02/13/2024$3.03$2.79-7.92%$2.90$2.7565,272 shs$155.07 million02/12/2024$3.06$3.03-0.98%$3.09$3.0227,531 shs$168.41 million02/09/2024$3.09$3.06-0.97%$3.12$3.0135,904 shs$170.08 million02/08/2024$2.99$3.09+3.34%$3.13$2.9848,831 shs$171.74 million02/07/2024$3.00$2.99-0.33%$3.01$2.8834,520 shs$166.18 million02/06/2024$2.90$3.00+3.45%$3.00$2.8510,393 shs$166.74 million02/05/2024$2.95$2.90-1.69%$2.98$2.8630,465 shs$161.18 million02/02/2024$2.95$2.95$3.02$2.8931,485 shs$163.97 million02/01/2024$3.00$2.95-1.67%$2.99$2.7533,156 shs$163.96 million01/31/2024$2.95$3.00+1.69%$3.05$2.8821,389 shs$166.74 million01/30/2024$3.03$2.95-2.64%$2.98$2.8914,883 shs$163.96 million01/29/2024$2.97$3.03+2.02%$3.04$2.8346,431 shs$168.41 million01/26/2024$2.79$2.97+6.45%$3.00$2.8189,568 shs$165.07 million Related Companies: ZURA Stock Price Chart MOLN Stock Price Chart DBVT Stock Price Chart AGEN Stock Price Chart VXRT Stock Price Chart OMGA Stock Price Chart SCLX Stock Price Chart VCXB Stock Price Chart CRDL Stock Price Chart GNFT Stock Price Chart Receive CLLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cellectis and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CLLS) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellectis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.